| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.044 | 0.8 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | 0.049 | 0.8 |